Lane H C, Masur H, Gelmann E P, Fauci A S
Cancer Res. 1985 Sep;45(9 Suppl):4674s-4676s.
The immune systems of patients with acquired immunodeficiency syndrome are characterized by a profound defect in the number and function of helper/inducer T-lymphocytes, particularly at the level of soluble antigen recognition. Due to this selective yet profound defect in the immune system, these patients are prone to recurrent severe opportunistic infections and Kaposi's sarcoma. While therapies exist for some of these complications of acquired immunodeficiency syndrome, no effective therapies exist for the underlying immune defect of this syndrome. Reviewed here are some of our recent attempts at immune reconstitution in acquired immunodeficiency syndrome, using either whole scale immune reconstitution through the use of lymphocyte transfers and bone marrow transplantation or enhancement of the remaining immune systems with the T-cell-derived lymphokines interleukin-2 or immune gamma-interferon. In addition, recent advances in the therapy of Pneumocystis carinii pneumonia and disseminated cytomegalovirus disease are discussed.
获得性免疫缺陷综合征患者的免疫系统特征为辅助/诱导性T淋巴细胞数量和功能存在严重缺陷,尤其是在可溶性抗原识别水平。由于免疫系统存在这种选择性但严重的缺陷,这些患者容易反复发生严重的机会性感染和卡波西肉瘤。虽然针对获得性免疫缺陷综合征的某些并发症有相应治疗方法,但对于该综合征潜在的免疫缺陷尚无有效治疗手段。本文回顾了我们最近在获得性免疫缺陷综合征免疫重建方面的一些尝试,包括通过淋巴细胞转移和骨髓移植进行全面免疫重建,或利用T细胞衍生的淋巴因子白细胞介素-2或免疫γ干扰素增强剩余的免疫系统。此外,还讨论了卡氏肺孢子虫肺炎和播散性巨细胞病毒病治疗方面的最新进展。